Neurofilament Blood Levels Likely to Predict Treatment Response in SMA

SMA News Today’s multimedia associate, Price Wooldridge, discusses a news article on how blood levels of phosphorylated neurofilament heavy chain, nerve cell damage marker, are related to greater motor gains in SMA infants, children.

Also, as treatments emerge, the SMA type system is evolving. DeAnn Runge talks about what she feels are the faults with the system. She also discusses how she'd like to see it change.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/